Overview

Title

To prohibit data brokers from selling and transferring certain sensitive data.

ELI5 AI

The "Health and Location Data Protection Act of 2024" is a rule that says companies can't sell or share people's health and location information without their okay. If they do, they might get in trouble and have to pay a big fine.

Summary AI

H.R. 10540, titled the "Health and Location Data Protection Act of 2024," aims to make it illegal for data brokers to sell or share individuals' location and health data without appropriate consent. Exceptions include actions compliant with HIPAA regulations, the publication of newsworthy information, or when the individual gives valid authorization. The Federal Trade Commission (FTC) is tasked with enforcing this law, and it can also be enforced by state attorneys general and private individuals. The bill provides for civil penalties and actions, allowing individuals to sue if their data rights are violated, and preempts conflicting state laws that require prohibited disclosures.

Published

2024-12-19
Congress: 118
Session: 2
Chamber: HOUSE
Status: Introduced in House
Date: 2024-12-19
Package ID: BILLS-118hr10540ih

Bill Statistics

Size

Sections:
5
Words:
2,490
Pages:
13
Sentences:
55

Language

Nouns: 764
Verbs: 188
Adjectives: 149
Adverbs: 19
Numbers: 89
Entities: 160

Complexity

Average Token Length:
4.25
Average Sentence Length:
45.27
Token Entropy:
5.21
Readability (ARI):
24.71

AnalysisAI

General Summary of the Bill

The proposed legislation, titled the "Health and Location Data Protection Act of 2024," aims to restrict the sale, transfer, and distribution of sensitive location and health data by data brokers. Introduced in the U.S. House of Representatives, the bill seeks to protect consumer privacy by making it unlawful for data brokers to mishandle personal data, especially concerning individuals' health status and geographic locations. The Federal Trade Commission (FTC) is tasked with enforcing these restrictions, and the bill outlines specific enforcement mechanisms and penalties for violations.

Summary of Significant Issues

The bill raises several significant concerns that need to be addressed for effective implementation and enforcement:

  1. Undefined Terms and Scope: The bill leaves certain terms like "other categories of data" and "appropriate equitable relief" broad and unspecified, potentially creating gaps in enforcement and interpretation.

  2. Enforcement and Jurisdiction Challenges: The FTC's power to enforce rules against nonprofit organizations lacks clear criteria, which may lead to inconsistencies. Additionally, the jurisdictional provisions might limit legal actions to specific courts, possibly complicating access to justice.

  3. Potential Impact on Businesses: The penalty structure based on 15 percent of the revenue of a parent company, irrespective of business diversity, may disproportionately affect companies not directly involved in the violation.

  4. Federal and State Legal Interactions: The bill does not sufficiently address how it will coexist with existing state laws, which might lead to complexities or conflicts in its application.

  5. Funding Concerns: The allocation of $1 billion without detailed expenditure justification raises concerns about financial oversight and potential misallocation of resources.

Impact on the Public

Broadly, this legislation could increase privacy protection for individuals, giving them greater control over who can access their sensitive health and location data. This could enhance consumer trust and security, especially in an age of increasing digital surveillance.

However, the general public might face challenges due to potential ambiguities in the bill that could lead to uneven enforcement or interpretation. It could also impact individuals' access to services that rely on data analysis for location-based solutions or advancements in health technologies.

Impact on Specific Stakeholders

Data Brokers and Businesses: Data brokers and businesses that depend on selling or analyzing health and location data could face significant operational changes. The increased regulatory scrutiny and potential for hefty penalties might deter innovation or lead to increased compliance costs, particularly affecting smaller companies or startups.

Nonprofit Organizations: The inclusion of nonprofit organizations under the FTC's enforcement radar could present challenges given their varied structures and objectives. Without explicit guidelines, nonprofits might face regulatory hurdles, despite being less involved in data commerce.

State Governments and Attorneys General: State-level enforcement mechanisms allow for local oversight, yet the requirement to align actions with federal efforts might lead to a reduction in state autonomy. States may experience limitations in pursuing localized data protection measures that address specific regional concerns.

Consumers and Advocacy Groups: Privacy advocates and consumers stand to benefit significantly from stronger data protection measures. Nevertheless, the bill's current ambiguities may necessitate continued advocacy to ensure comprehensive protections are realized in practical terms.

In conclusion, while the bill represents a positive step toward modernizing privacy laws in response to growing digital data concerns, it must address the identified issues to ensure fair and effective implementation. Balancing rigorous data protection with economic considerations and legal clarity will be crucial for its success.

Financial Assessment

In reviewing H.R. 10540, the "Health and Location Data Protection Act of 2024," the financial aspect centers around a single appropriation designed to fund enforcement activities. The proposed appropriation is substantial, and there are several implications and concerns related to its allocation.

Financial Allocation Overview

H.R. 10540 includes a financial provision in Section 5 that allocates $1,000,000,000 to the Federal Trade Commission (FTC) for fiscal year 2025. This funding is drawn from money in the Treasury that is not otherwise appropriated and is set to remain available until September 30, 2034. This allocation is meant to support the FTC's activities under this Act, indicating a long-term commitment to enforce the prohibitions on data brokers regarding sensitive data.

Relation to Identified Issues

The allocation of $1,000,000,000 directly touches on several issues surrounding the bill:

  1. Significance of the Appropriation Size: The allocation is notably large and raises questions about the necessity and future use of such a significant sum of money. The issue identified concerns potential wasteful spending due to the lack of detailed justification or explicit breakdown of how this funding will be deployed. Understanding the specific costs associated with enforcing the bill's provisions, such as the technology needed for monitoring and compliance, personnel expenses, and other operational costs, would provide clarity on this substantial expenditure.

  2. Efficiency and Accountability Concerns: Without a detailed plan, stakeholders might be concerned that the funds won't be used efficiently or, worse, misallocated. There is no clarification within the bill regarding checks or measures to ensure the funds are spent wisely over the next nine years. As a public allocation, this money should be subject to stringent oversight to avoid misuse and ensure it serves its intended purpose effectively.

  3. Potential for Legal and Regulatory Challenges: The issues related to potential legal challenges due to ambiguity in some definitions and enforcement expectations could lead to prolonged litigation or administrative costs. The financial allocation must anticipate such expenditures, which could detract from its primary purpose of protecting consumers under the new regulations.

  4. Impact on Enforcement Activities: The funding is meant to bolster the FTC's enforcement capabilities, which involves dealing with complexities like nonprofit organizations and the interplay between federal and state laws. It is crucial that the money supports activities that enhance the FTC's ability to manage these sophisticated aspects adequately.

Overall, the financial provisions within H.R. 10540 highlight the government's substantial commitment to safeguarding sensitive data. However, the absence of detailed financial planning could lead to inefficiencies. Clear guidelines and accountability measures regarding the use of these funds would mitigate these concerns and ensure effective implementation of the Act's objectives.

Issues

  • The enforcement powers granted to the Federal Trade Commission (FTC) regarding nonprofit organizations in Section 3 do not specify any limitations or criteria, potentially leading to overly broad or inconsistent application.

  • The provision in Section 3 regarding civil penalties based on 15 percent of the revenues of the ultimate parent entity could disproportionately impact companies with diversified business lines unrelated to the violation, raising fairness concerns.

  • The term 'appropriate equitable relief' used throughout Section 3 is vague and could lead to inconsistent interpretations and enforcement actions, potentially affecting predictability and fairness in legal proceedings.

  • The definition and scope of 'other categories of data' in Section 2 are not clearly specified, leading to potential ambiguity in enforcement and understanding.

  • The process and criteria by which the Commission will identify and address new categories of data in Section 2 are not detailed, which could lead to arbitrary decision-making.

  • The timeline for the prohibition's effective date in Section 2 could cause confusion if the Commission does not issue a rule exactly 180 days after the enactment due to the phrasing 'the earlier of'.

  • The phrase 'newsworthy information of legitimate public concern' in Section 2 is subjective and may require additional specification to prevent misuse, impacting media freedom and privacy protections.

  • The allocation of $1,000,000,000 in Section 5 is a significant expenditure without detailed justification or breakdown of costs, raising concerns about potential wasteful spending and efficient use of taxpayer money.

  • The interaction between this federal act and existing state laws is not comprehensively addressed, particularly regarding overlap or conflicts outside of disclosure requirements, potentially leading to legal challenges or confusion, as noted in Section 3.

  • The term 'valid authorization' in Section 2 refers to another regulation for its definition, which might require readers to reference additional documents, complicating understanding and compliance for stakeholders.

Sections

Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.

1. Short title Read Opens in new tab

Summary AI

The Health and Location Data Protection Act of 2024 is the official name given to this legislative act.

2. Unfair and deceptive acts and practices relating to health and location data Read Opens in new tab

Summary AI

The section makes it illegal for data brokers to sell, share, or transfer people's location and health data without permission, with exceptions for actions that comply with HIPAA, publishing newsworthy information, and sharing data with valid authorization. It requires the Federal Trade Commission to issue rules to enforce this, effective no later than 180 days post-enactment.

3. Enforcement Read Opens in new tab

Summary AI

The section outlines how the Federal Trade Commission (FTC), states, and individuals can enforce the rules against data brokers that violate the act. It explains the roles of the FTC and state attorneys general in bringing civil actions, specifies penalties for violations, determines where legal actions can be filed, and sets a 6-year time limit to start legal proceedings.

4. Definitions Read Opens in new tab

Summary AI

The section defines key terms used in the Act, detailing the roles and meanings of the Commission, data, data broker, health data, location data, State, and ultimate parent entity. It specifies that "data" refers to information linked to individuals or groups, "health data" covers various health-related information, and outlines what constitutes "location data."

5. Funding Read Opens in new tab

Summary AI

For the fiscal year 2025, the Commission is allocated $1 billion from the Treasury, which will be available until September 30, 2034, to support its operations.

Money References

  • In addition to amounts otherwise available, there is appropriated to the Commission for fiscal year 2025, out of any money in the Treasury not otherwise appropriated, $1,000,000,000, to remain available until September 30, 2034, for carrying out the work of the Commission.